"HLA Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases.
Descriptor ID |
D006680
|
MeSH Number(s) |
D23.050.301.500.450 D23.050.705.552.450
|
Concept/Terms |
HLA Antigens- HLA Antigens
- Antigens, HLA
- HL-A Antigens
- Antigens, HL-A
- HL A Antigens
- Human Leukocyte Antigens
- Antigens, Human Leukocyte
- Leukocyte Antigens, Human
- Leukocyte Antigens
- Antigens, Leukocyte
|
Below are MeSH descriptors whose meaning is more general than "HLA Antigens".
Below are MeSH descriptors whose meaning is more specific than "HLA Antigens".
This graph shows the total number of publications written about "HLA Antigens" by people in this website by year, and whether "HLA Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 |
1995 | 3 | 0 | 3 |
1996 | 4 | 1 | 5 |
1997 | 4 | 1 | 5 |
1998 | 3 | 2 | 5 |
1999 | 1 | 2 | 3 |
2000 | 2 | 0 | 2 |
2001 | 1 | 1 | 2 |
2002 | 3 | 0 | 3 |
2003 | 1 | 4 | 5 |
2004 | 2 | 0 | 2 |
2005 | 3 | 1 | 4 |
2006 | 2 | 1 | 3 |
2007 | 2 | 1 | 3 |
2008 | 0 | 3 | 3 |
2009 | 1 | 3 | 4 |
2010 | 3 | 4 | 7 |
2011 | 3 | 1 | 4 |
2012 | 3 | 2 | 5 |
2013 | 2 | 3 | 5 |
2014 | 3 | 3 | 6 |
2015 | 3 | 1 | 4 |
2016 | 4 | 1 | 5 |
2017 | 3 | 2 | 5 |
2018 | 4 | 2 | 6 |
2019 | 6 | 3 | 9 |
2020 | 1 | 3 | 4 |
2021 | 7 | 1 | 8 |
2022 | 0 | 4 | 4 |
2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "HLA Antigens" by people in Profiles.
-
Characterizing the risk of human leukocyte antigen-incompatible living donor kidney transplantation in older recipients. Am J Transplant. 2023 Dec; 23(12):1980-1989.
-
Donor programmed cell death 1 ligand 1 is required for organ transplant tolerance in major histocompatibility complex-mismatched mixed chimeras although programmed cell death 1 ligand 1 and major histocompatibility complex class II are not required for inducing chimerism. Am J Transplant. 2023 08; 23(8):1116-1129.
-
Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy. Nature. 2023 03; 615(7953):697-704.
-
Non-viral precision T?cell receptor replacement for personalized cell therapy. Nature. 2023 03; 615(7953):687-696.
-
From bench to bedside: reversing established antibody responses and desensitization. Curr Opin Organ Transplant. 2022 10 01; 27(5):376-384.
-
Toward an understanding of allogeneic conflict in pregnancy and transplantation. J Exp Med. 2022 05 02; 219(5).
-
De novo human leukocyte antigen allosensitization patterns in patients bridged to heart transplantation using left ventricular assist devices. Transpl Immunol. 2022 06; 72:101567.
-
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia. Nat Commun. 2021 10 29; 12(1):6233.
-
A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response. Nat Genet. 2021 10; 53(10):1504-1516.
-
A pan-cancer organoid platform for precision medicine. Cell Rep. 2021 07 27; 36(4):109429.